Liquidia Technologies (LQDA) Announces Poster Presentations at the PHA 2024 International
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Liquidia Announces Poster Presentations at the PHA 2024 International PH Conference and Scientific Sessions
August 16, 2024 6:30 AM EDTMORRISVILLE, N.C., Aug. 16, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), announced today the company will present nine encore thematic posters at the PHA 2024 International PH Conference and Scientific Sessions taking place August 15 to August 18, 2024 in Indianapolis, Indiana.
The companys posters, which will be presented on Friday, August 16, 2024 from 8:00 a.m. 5:30 p.m. EDT and Saturday, August 17, 2024 from 9:00 a.m. 1:00 p.m. EDT, focus on the companys investigational products, YUTREPIA (treprostinil) inhalation powder, and L606 (liposomal treprostinil) inhalation suspension sustained-release formulation, both for the potential treatment of patients with pulmonary... More
